Costa Barbara, Fletcher Michael N C, Boskovic Pavle, Ivanova Ekaterina L, Eisemann Tanja, Lohr Sabrina, Bunse Lukas, Löwer Martin, Burchard Stefanie, Korshunov Andrey, Coltella Nadia, Cusimano Melania, Naldini Luigi, Liu Hai-Kun, Platten Michael, Radlwimmer Bernhard, Angel Peter, Peterziel Heike
Division of Signal Transduction and Growth Control, DKFZ-ZMBH Alliance, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Division of Molecular Genetics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Cancers (Basel). 2021 Jan 10;13(2):230. doi: 10.3390/cancers13020230.
Glioblastomas (GBM) are the most aggressive tumors affecting the central nervous system in adults, causing death within, on average, 15 months after diagnosis. Immunocompetent in-vivo models that closely mirror human GBM are urgently needed for deciphering glioma biology and for the development of effective treatment options. The murine GBM cell lines currently available for engraftment in immunocompetent mice are not only exiguous but also inadequate in representing prominent characteristics of human GBM such as infiltrative behavior, necrotic areas, and pronounced tumor heterogeneity. Therefore, we generated a set of glioblastoma cell lines by repeated in vivo passaging of cells isolated from a neural stem cell-specific double-knockout genetic mouse brain tumor model. Transcriptome and genome analyses of the cell lines revealed molecular heterogeneity comparable to that observed in human glioblastoma. Upon orthotopic transplantation into syngeneic hosts, they formed high-grade gliomas that faithfully recapitulated the histopathological features, invasiveness and immune cell infiltration characteristic of human glioblastoma. These features make our cell lines unique and useful tools to study multiple aspects of glioblastoma pathomechanism and to test novel treatments in an intact immune microenvironment.
胶质母细胞瘤(GBM)是影响成人中枢神经系统的最具侵袭性的肿瘤,平均在诊断后15个月内导致死亡。迫切需要能够密切反映人类GBM的具有免疫活性的体内模型,以解读胶质瘤生物学特性并开发有效的治疗方案。目前可用于植入具有免疫活性小鼠体内的鼠GBM细胞系不仅数量稀少,而且在体现人类GBM的突出特征(如浸润行为、坏死区域和明显的肿瘤异质性)方面也存在不足。因此,我们通过从神经干细胞特异性双敲除基因小鼠脑肿瘤模型中分离的细胞进行反复体内传代,建立了一组胶质母细胞瘤细胞系。对这些细胞系的转录组和基因组分析揭示了与人类胶质母细胞瘤中观察到的分子异质性相当的情况。将它们原位移植到同基因宿主中后,形成了高级别胶质瘤,忠实地再现了人类胶质母细胞瘤的组织病理学特征、侵袭性和免疫细胞浸润特性。这些特性使我们的细胞系成为研究胶质母细胞瘤发病机制多个方面以及在完整免疫微环境中测试新疗法的独特且有用的工具。